4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)Transfusion-dependent Alpha-Thalassemia; Transfusion-dependent Beta-ThalassemiaActive, not recruitingPhase 32026-09-28NCT04770779
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)Non-Transfusion-dependent Alpha-Thalassemia; Non-Transfusion-dependent Beta-ThalassemiaActive, not recruitingPhase 32026-09-28NCT04770753
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-ThalassemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, alpha thalassemia spectrum, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemiaActive, not recruitingPhase 22026-09-10NCT05664737
Selatogrel Outcome Study in Suspected Acute Myocardial Infarctionacute myocardial infarctionEnrolling by invitationPhase 32026-07-23NCT04957719